Zhejiang Ausun Pharmaceutical Co., Ltd.

SHSE:603229 Stok Raporu

Piyasa değeri: CN¥6.9b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Zhejiang Ausun Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Zhejiang Ausun Pharmaceutical has been growing earnings at an average annual rate of 32.9%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 22.9% per year. Zhejiang Ausun Pharmaceutical's return on equity is 11.8%, and it has net margins of 32.5%.

Anahtar bilgiler

32.9%

Kazanç büyüme oranı

30.9%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi10.9%
Gelir büyüme oranı22.9%
Özkaynak getirisi11.8%
Net Marj32.5%
Sonraki Kazanç Güncellemesi30 Oct 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Shares Find Their Feet

Jul 31
Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Shares Find Their Feet

Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Mar 06
Improved Earnings Required Before Zhejiang Ausun Pharmaceutical Co., Ltd. (SHSE:603229) Stock's 27% Jump Looks Justified

Gelir ve Gider Dağılımı

Zhejiang Ausun Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SHSE:603229 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 2484027410871
31 Mar 2480025012677
31 Dec 2381725411878
30 Sep 2385828412588
30 Jun 2385227314286
31 Mar 2382225812278
31 Dec 2276523511867
30 Sep 2271821311072
30 Jun 226651869464
31 Mar 226311738464
31 Dec 215701468369
30 Sep 215371317657
30 Jun 214851176650
31 Mar 214741106952
31 Dec 20409876351
30 Sep 20406727161
30 Jun 20389786967
31 Mar 20329706055
31 Dec 19308565748
30 Sep 19293624941
30 Jun 19257515036
31 Mar 19252504837
31 Dec 18244444534
30 Sep 18255544834
30 Jun 18266523244
31 Mar 18251433835
31 Dec 17240534130
30 Sep 17217553819
30 Jun 1721662530
31 Mar 1719758480
31 Dec 1619957480
31 Mar 1625962650
31 Dec 1526361650
31 Dec 1420122740
31 Dec 1312116310

Kaliteli Kazançlar: 603229 has high quality earnings.

Büyüyen Kar Marjı: 603229's current net profit margins (32.5%) are higher than last year (32%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 603229's earnings have grown significantly by 32.9% per year over the past 5 years.

Büyüme Hızlandırma: 603229's earnings growth over the past year (0.4%) is below its 5-year average (32.9% per year).

Kazançlar vs. Sektör: 603229 earnings growth over the past year (0.4%) exceeded the Pharmaceuticals industry -0.6%.

Özkaynak Getirisi

Yüksek ROE: 603229's Return on Equity (11.8%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y